Clinical Trials Logo

Filter by:
NCT ID: NCT00446420 Completed - Clinical trials for Cognitive Impairment

Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations

Start date: February 2007
Phase: Phase 4
Study type: Interventional

Our hypothesis is that adding midazolam and/or fentanyl to propofol sedation for elective outpatient colonoscopy increases cognitive impairment at hospital discharge without improving intraoperative conditions or reducing intraoperative side-effects. 200 healthy patients aged 18 years or older will be randomised to receive propofol or propofol plus midazolam and/or fentanyl. Cognitive impairment will be tested at hospital discharge using Cogstate computerised testing software.

NCT ID: NCT00446212 Completed - Anaesthesia Clinical Trials

Dreaming and EEG Changes During Anaesthesia Maintained With Propofol or Desflurane

Start date: August 2006
Phase: Phase 4
Study type: Interventional

We hypothesise that patients who receive propofol for maintenance of anaesthesia will report dreaming more often when they emerge from anaesthesia than patients who receive desflurane for maintenance of anaesthesia.

NCT ID: NCT00445718 Completed - Clinical trials for Precancerous Condition

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Start date: July 2001
Phase: N/A
Study type: Observational

This natural history study is collecting health information about infants with adrenal masses found on prenatal and/or neonatal imaging. Gathering information over time from imaging and laboratory tests of infants with adrenal masses may help doctors learn more about the disease and plan the best treatment.

NCT ID: NCT00443248 Completed - Clinical trials for Sexual Dysfunction, Physiological

Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).

FSAD HWO VBF
Start date: March 2007
Phase: Phase 1
Study type: Interventional

The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data are collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess the technique's ability to differentiate between pre- and post-menopausal women; with and without Female Sexual Arousal Disorder (FSAD).

NCT ID: NCT00443170 Completed - Healthy Subjects Clinical Trials

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Start date: November 2006
Phase: Phase 1
Study type: Interventional

This is a first time in human study to investigate the safety of GSK626616AC given as oral single and repeat doses in healthy subjects. An additional group of subjects will be assessed to determine the effect of several drugs given at the same time as GSK626616.

NCT ID: NCT00443027 Completed - Clinical trials for Sexual Dysfunction, Physiological

Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.

HWO VBF
Start date: March 2007
Phase: Phase 1
Study type: Interventional

The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data is collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess changes in vaginal blood flow across the menstrual cycle following visual sexual stimulation.

NCT ID: NCT00442702 Completed - Anemia Clinical Trials

A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.

Start date: September 2007
Phase: Phase 3
Study type: Interventional

This 2 arm study will compare the efficacy and safety of Mircera and darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease who are not on dialysis and who are receiving subcutaneous darbepoetin alfa maintenance therapy. Patients will be randomized either to remain on darbepoetin alfa therapy as per local label, or to switch to monthly subcutaneous Mircera, at a starting dose of 120, 200 or 360 micrograms, depending on the weekly dose of darbepoetin alfa administered prior to the first dose of Mircera. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.

NCT ID: NCT00441727 Completed - Gastric Ulcer Clinical Trials

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)

Oberon
Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effect of esomeprazole 20 or 40 mg once daily versus placebo on the occurrence of peptic ulcers during 26 weeks in subjects on continuous low-dose acetylsalicylic acid.

NCT ID: NCT00441441 Completed - Asthma Clinical Trials

A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

Start date: February 2007
Phase: Phase 3
Study type: Interventional

This study is to assess the safety of an investigational drug in children 4 to 11 years of age who have asthma. The subjects will attend 7 clinic visits, of which up to 3 will be in the morning, and have lung function tests performed.

NCT ID: NCT00441233 Completed - Myopia Clinical Trials

Clinical Performance of Extended Wear Silicone Hydrogel Lenses

Start date: March 2007
Phase: N/A
Study type: Interventional

The primary purpose of this study is to investigate the clinical performance of a new silicone hydrogel contact lens over a period of 6 months of extended wear.